43
Participants
Start Date
October 30, 2020
Primary Completion Date
February 25, 2021
Study Completion Date
April 30, 2021
lanadelumab
single dose, or two doses administered iv
regular care
no lanadelumab administration, treated according to regular care
Amsterdam UMC, Amsterdam
Rijnstate hospital, Arnhem
Radboudumc, Nijmegen
UMC Utrecht, Utrecht
Collaborators (1)
Takeda
INDUSTRY
Radboud University Medical Center
OTHER